by The global traumatic brain injury assessment and management devices market size is expected to be worth around US$ 10.5 billion by 2030, according to a new report by Vision Research Reports.
The global traumatic brain injury assessment and management devices market size was valued at US$ 3.9 billion in 2020 and is anticipated to grow at a CAGR of 9.3% during forecast period 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38819
Table of Contents
Traumatic Brain Injury Assessment and Management Devices Market Growth Factors
The increasing prevalence of traumatic brain injuries (TBIs), rising patients’ preference for minimally invasive procedures, and rising awareness regarding brain injuries are the major factors expected to fuel the market growth. In addition, the adoption of technologically advanced products and supportive government policies are few more factors contributing to the market growth. Traumatic brain injuries are permanent or temporary impairment to the brain that can be caused by a blow, bump, or shock to the skull. Major causes of TBIs include sports injuries, falls, gunshot wounds, domestic violence, and road traffic accidents.
Traumatic Brain Injury Assessment and Management Devices Market Report Coverage
| Report Scope | Details |
| Market Size | US$ 10.5 Bn by 2030 |
| Growth Rate | CAGR of 9.3% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Device, technique, end-use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Companies Mentioned | BioDirection, Inc.; BrainScope Company, Inc.; Neural Analytics, Inc.; Compumedics Ltd.; Integra LifeSciences; Natus Medical, Inc. |
By Device Analysis
The imaging devices segment dominated the market with a share of 55.04% in 2020. The imaging devices are further segmented into computed tomography (CT), magnetic resonance imaging (MRI) devices, X-ray, and others.
The monitoring devices segment is expected to expand at the highest CAGR of 9.6% from 2021 to 2030 owing to the minimally invasive nature of these devices, increasing awareness, and improvement in healthcare facilities.
By Technique Analysis
The intracranial pressure (ICP) monitoring segment dominated the market with a share of 55.61% in 2020. This method is considered to be a gold standard for the accurate measurement of intracranial pressure in patients with severe brain injury.
The partial pressure of oxygen in the brain tissue (pBrO2) segment is expected to expand at the highest CAGR of 8.10% from 2021 to 2030. Continuous pBrO2 monitoring provides timely information about cerebral oxygen demand in patients suffering from traumatic brain injury.
By End-use Analysis
The hospitals’ segment dominated the market with a share of 43.17% in 2020 owing to the increase in the number of brain surgeries performed in hospitals as well as a surge in the prevalence of TBIs patients globally.
The others’ segment including ambulatory surgical centers, research centers, and emergency clinics is expected to expand at the highest CAGR of 8.10% from 2021 to 2030. This is attributed to numerous advantages offered by emergency clinics and ASCs such as shorter procedure time and same-day discharge as compared to hospitals.
By Regional Analysis
North America dominated the market with a share of 53.73% in 2020. This is attributed to the presence of well-established healthcare facilities in the region, increasing government initiatives, awareness campaigns regarding brain injuries, and greater incidence of traumatic brain injuries in the region.
The Asia Pacific region is expected to expand at the highest CAGR of 10.9% from 2021 to 2030. This is attributed to factors such as growth in the aging population, rise in the number of people suffering from traumatic brain injuries, increasing incidence of road accidents, and violence.
Read also @ Biopharmaceutical Third Party Logistics Market Size, Share by 2030
Major Key Players Covered in The Traumatic Brain Injury Assessment and Management Devices Market Report include
- BrainScope Company, Inc.
- Neural Analytics, Inc.
- Advanced Brain Monitoring Inc.
- Natus Medical, Inc.
- Integra Lifesciences
- BioDirection, Inc.
- Nihon Kohden Corporation
- Compumedics Ltd.
- InfraScan, Inc.
- Oculogica
- Raumedic AG
Traumatic Brain Injury Assessment and Management Devices Market Segmentation
- By Device
- Imaging Devices
- Magnetic Resonance Imaging (MRI) Devices
- X-ray
- Computed Tomography
- Others
- Monitoring Devices
- Imaging Devices
- By Technique
- Intracranial Pressure (ICP) Monitoring
- Partial Pressure of Oxygen in Brain Tissue (pBrO2)
- By End-use
- Hospitals
- Diagnostic Centers
- Others
- Regional
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Traumatic Brain Injury Assessment and Management Devices Market Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions and Limitations
Chapter 3. Traumatic Brain Injury Assessment and Management Devices Market Executive Summary
3.1. Traumatic Brain Injury Assessment and Management Devices Market Snapshot
Chapter 4. Traumatic Brain Injury Assessment and Management Devices Market Variables and Scope
4.1. Introduction
4.2. Traumatic Brain Injury Assessment and Management Devices Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Traumatic Brain Injury Assessment and Management Devices Market Dynamics Analysis and Trends
5.1. Traumatic Brain Injury Assessment and Management Devices Market Dynamics
5.1.1. Traumatic Brain Injury Assessment and Management Devices Market Drivers
5.1.2. Traumatic Brain Injury Assessment and Management Devices Market Restraints
5.1.3. Traumatic Brain Injury Assessment and Management Devices Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Traumatic Brain Injury Assessment and Management Devices Market, By Device
7.1. Traumatic Brain Injury Assessment and Management Devices Market, by Device, 2021-2030
7.1.1. Imaging Devices
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Monitoring Devices
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Traumatic Brain Injury Assessment and Management Devices Market, By Technique
8.1. Traumatic Brain Injury Assessment and Management Devices Market, by Technique, 2021-2030
8.1.1. Intracranial Pressure (ICP) Monitoring
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Partial Pressure of Oxygen in Brain Tissue (pBrO2)
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Traumatic Brain Injury Assessment and Management Devices Market, By End User
9.1. Traumatic Brain Injury Assessment and Management Devices Market, by End User, 2021-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Diagnostic Centers
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Traumatic Brain Injury Assessment and Management Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Device (2017-2030)
10.1.2. Market Revenue and Forecast, by Technique (2017-2030)
10.1.3. Market Revenue and Forecast, by End User (2017-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Device (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Technique (2017-2030)
10.1.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Device (2017-2030)
10.1.5.2. Market Revenue and Forecast, by Technique (2017-2030)
10.1.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Device (2017-2030)
10.2.2. Market Revenue and Forecast, by Technique (2017-2030)
10.2.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Device (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Technique (2017-2030)
10.2.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Device (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Technique (2017-2030)
10.2.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Device (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Technique (2017-2030)
10.2.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Device (2017-2030)
10.2.7.2. Market Revenue and Forecast, by Technique (2017-2030)
10.2.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Device (2017-2030)
10.3.2. Market Revenue and Forecast, by Technique (2017-2030)
10.3.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Device (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Technique (2017-2030)
10.3.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Device (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Technique (2017-2030)
10.3.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Device (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Technique (2017-2030)
10.3.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Device (2017-2030)
10.3.7.2. Market Revenue and Forecast, by Technique (2017-2030)
10.3.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Device (2017-2030)
10.4.2. Market Revenue and Forecast, by Technique (2017-2030)
10.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Device (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Technique (2017-2030)
10.4.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Device (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Technique (2017-2030)
10.4.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Device (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Technique (2017-2030)
10.4.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Device (2017-2030)
10.4.7.2. Market Revenue and Forecast, by Technique (2017-2030)
10.4.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Device (2017-2030)
10.5.2. Market Revenue and Forecast, by Technique (2017-2030)
10.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Device (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Technique (2017-2030)
10.5.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Device (2017-2030)
10.5.5.2. Market Revenue and Forecast, by Technique (2017-2030)
10.5.5.3. Market Revenue and Forecast, by End User (2017-2030)
Chapter 11. Company Profiles
11.1. BrainScope Company, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Neural Analytics, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Advanced Brain Monitoring Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Natus Medical, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Integra Lifesciences
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. BioDirection, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Nihon Kohden Corporation
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Compumedics Ltd.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. InfraScan, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Oculogica
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38819
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
